LAS VEGAS - January 6, 2025 (NEWMEDIAWIRE) - Femto Technologies Inc. (Nasdaq: BCAN) ("Femto" or the "Company"), a Femtech pioneer and the creator of Sensera, a holistic self-care feminine wellness device equipped with biofeedback sensors and AI capabilities, will showcase its innovative product at ShowStoppers(R) CES. This event is the meeting ground for top tech media representatives, industry analysts, and tech entrepreneurs, alongside the world's most innovative brands and startups.
As a CES Innovation Awards(R) 2025 honoree in the AI category, Femto will present the Sensera product at ShowStoppers(R), offering a global audience of leaders a preview of its upcoming launch in the US market.
Femto's proprietary SRS technology enables Sensera to provide a unique experience designed to adapt to a woman's changing needs over time, using AI, machine learning, and biofeedback sensors. Sensera personalizes the feminine usability experience, bridging the gap between wellness and pleasure. More information is available on the company's website.
"We are excited to provide a sneak peek of Sensera at ShowStoppers(R) CES," said Yftah Ben Yaackov, CEO of Femto. "Sensera represents a high-end Femtech device at the intersection of our cutting-edge SRS technology and AI, enabling a feminine-led product architecture. We're thrilled to begin our first steps to market."
Sensera's feminine wellness device includes a charging cable, storage sachet, quick start guide, and three interchangeable pods: two for pleasure and one for wellness. It will be available for pre-order in Q1 at www.senserawellness.com. Additional capsules can be purchased separately as a one-time order or via subscription. Pre-orders are scheduled to ship in early Q2 2025.
About ShowStoppers(R)
ShowStoppers(R) @ CES is the world's most influential technology showcase for media, giving a global audience of journalists access to major brands and startups, as well as the industry's most influential leaders and advocates.
About Sensera
Sensera is a feminine wellness device on a mission to bridge the gap between feminine pleasure and wellness, providing a holistic self-care experience that adapts to a woman's changing needs. Sensera utilizes Femto's proprietary Smart Release System (SRS) technology, including machine learning and AI, to enhance feminine wellness. Sensera is a CES Innovation Awards(R) 2025 Honorary in the AI category.
Femto Technologies Inc. (Nasdaq: BCAN), previously known as BYND Cannasoft Enterprises Inc., is a public Femtech company, pioneering a transformative change in the sphere of female wellness. Its proprietary Smart Release System (SRS technology) is embedded in Sensera, which has been named CES Innovation Awards(R) 2025 honoree in the AI category. Femto's SRS technology is driving its R&D activities and product manufacturing for a variety of Femtech products.
The devices described in this news release are concept devices that are in the first stage of development and will be subject to testing, experiments and regulatory approvals and therefore there is no certainty that they will eventually be marketed.
For more information, please visit www.femtocorp.com and on SEDAR+: www.sedarplus.ca.
This press release includes certain statements that may be deemed "forward-looking statements" within the meaning of Section 27A of the U.S. Securities Act of 1933, as amended, and Section 21E of the U.S. Securities Exchange Act of 1934, as amended and under Canadian securities laws. When used in this press release, the words "may", "would", "could", "will", "intend", "plan", "anticipate", "believe", "estimate", "expect" and similar expressions are intended to identify forwardlooking statements. Such statements are subject to certain risks and uncertainties, and actual circumstances, events or results may differ materially from those projected in such forward-looking statements.
Although the Company believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance, and actual events or developments may differ materially from those in forward-looking statements. Such forward-looking statements necessarily involve known and unknown risks and uncertainties, which may cause the Company's actual performance and financial results in future periods to differ materially from any projections of future performance or results expressed or implied by such forward-looking statements. Such statements reflect the Company's current views with respect to future events and are subject to such risks and uncertainties. Many factors could cause actual results to differ materially from the statements made, including future financial performance, unanticipated regulatory requests and delays, final patents approval, timing of the Sensera pre-order and those factors discussed in filings made by the company with the Canadian securities regulatory authorities, including (without limitation) in the company's management's discussion and analysis for the year ended December 31, 2023 and annual information form dated April 2, 2024, which are available under the company's profile at www.sedarplus.ca, and in the Company's Annual Report on Form 20-F for the year then ended that was filed with the U.S. Securities and Exchange Commission on April 3, 2024. Should one or more of these factors occur, or should assumptions underlying the forward-looking statements prove incorrect, actual results may vary materially from those described herein as intended, planned, anticipated, or expected. We do not intend and do not assume any obligation to update these forwardlooking statements, except as required by law. Any such forward-looking statements represent management's estimates as of the date of this press release. While we may elect to update such forward-looking statements at some point in the future, we disclaim any obligation to do so, even if subsequent events cause our views to change. Shareholders are cautioned not to put undue reliance on such forwardlooking statements.
